JLABS | Paths to the patient: Business models for drug discovery and development
How do you choose the right path to bring your drug discovery to patients? Join this JLABS program to discover the pros and cons.
3 June 2025 | 13:00 – 18:00 CEST | Utrecht & virtual
Turning a drug discovery into patient impact means choosing the right development path and knowing when to pivot. But how do you choose the best route for your drug?
Join Johnson & Johnson’s upcoming program as they bring together experts who have successfully traveled these paths and are ready to share insights into various development routes. Topics include academic-industry partnerships, IP strategies, spin-off creation, funding, and more.
Don’t miss your chance to gain clarity on the pros and cons of different paths for your scientific breakthrough.
Start-ups, early innovators and entrepreneurs are welcome to register here.